HAEMONETICS CORP shareholders Q3 2023

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

HAEMONETICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Aspire Private Capital, LLC 75$6,7180.00%
MERCER GLOBAL ADVISORS INC /ADV 4,688$4200.00%
Hexagon Capital Partners LLC 73$6,5390.00%
UBS ASSET MANAGEMENT AMERICAS LLC 62,024$5,556,1090.00%
AMERICAN CENTURY COMPANIES INC 27,308$2,446,2510.00%
Lindbrook Capital, LLC 247$22,1260.00%
NISA INVESTMENT ADVISORS, LLC 1,227$109,9150.00%
UBS Group AG 44,469$3,983,5330.00%
HSBC HOLDINGS PLC 9,812$886,9180.00%
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO 2,821$253,0000.00%
WELLS FARGO & COMPANY/MN 30,932$2,770,8440.00%
STIFEL FINANCIAL CORP 4,802$430,1660.00%
PNC FINANCIAL SERVICES GROUP, INC. 9,114$816,4340.00%
BANK OF AMERICA CORP /DE/ 144,125$12,910,7180.00%
Parallel Advisors, LLC 233$20,8720.00%
ACADIAN ASSET MANAGEMENT LLC 1,915$1710.00%
JENNISON ASSOCIATES LLC 6,810$610,0400.00%
TRUIST FINANCIAL CORP 3,750$335,9250.00%
WOLVERINE TRADING, LLC 5,475$490,4510.00%
Pictet Asset Management Holding SA 5,746$514,7270.00%
External links

This page lists HAEMONETICS CORP's shareholders in Q3 2023. To view HAEMONETICS CORP's shareholder history, click here.